The pharmacological correction of immunologic impairments in rheumatoid arthritis patients
The diagnostic criteria of management effectiveness were investigated in rheumatoid arthritis patients. The outcomes of base-line immunodeficiency were investigated. Special conditions of strengthening of basic therapy by cytostatics were revealed. Basic levels of physical and psyhic conditions scores in rheumatoid arthritis patients with such strengthening were identified. The treatment strategy for rheumatoid arthritis patients with combined T-and B-cells immunodeficiency and a low base-line quality of life score was defined. The dynamics of quality of life scores were studied depending immunodeficiency outcomes. The relationship between immune system condition and quality of life scores was proved.